These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16103866)

  • 1. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
    Russell JW
    Nat Clin Pract Neurol; 2006 Jan; 2(1):18-9. PubMed ID: 16932514
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic peripheral neuropathic pain: recognition and management.
    Cole BE
    Pain Med; 2007 Sep; 8 Suppl 2():S27-32. PubMed ID: 17714113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.
    Gao Y; Ning G; Jia WP; Zhou ZG; Xu ZR; Liu ZM; Liu C; Ma JH; Li Q; Cheng LL; Wen CY; Zhang SY; Zhang Q; Desaiah D; Skljarevski V
    Chin Med J (Engl); 2010 Nov; 123(22):3184-92. PubMed ID: 21163113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    O'Connor AB
    J Pain; 2006 Nov; 7(11):867; author reply 867-8. PubMed ID: 17074629
    [No Abstract]   [Full Text] [Related]  

  • 7. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall J; Meyers AL; Gonzales J; Mallinckrodt C
    J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies.
    Wu N; Chen SY; Hallett LA; Boulanger L; Fraser KA; Patel CK; Zhao Y
    Pain Pract; 2011; 11(1):48-56. PubMed ID: 20602718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety profile of treatment in diabetic peripheral neuropathic pain.
    Robinson-Papp J; Simpson DM
    Pain Med; 2007 Sep; 8 Suppl 2():S43-9. PubMed ID: 17714115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of duloxetine on primary pain symptoms in Parkinson disease.
    Djaldetti R; Yust-Katz S; Kolianov V; Melamed E; Dabby R
    Clin Neuropharmacol; 2007; 30(4):201-5. PubMed ID: 17762316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall JA; Risser RC; Gonzales JS
    Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant agents for the treatment of chronic pain and depression.
    Jann MW; Slade JH
    Pharmacotherapy; 2007 Nov; 27(11):1571-87. PubMed ID: 17963465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New hope in the treatment of painful symptoms in depression.
    Briley M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):42-5. PubMed ID: 12625027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
    Westanmo AD; Gayken J; Haight R
    Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a place for duloxetine?
    Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine's role in the treatment of depression and associated painful physical symptoms.
    Wohlreich MM; Watkin JG; Gonzales JS
    J Clin Psychiatry; 2004 Jul; 65(7):1018-9. PubMed ID: 15291696
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
    Ziegler D; Pritchett YL; Wang F; Desaiah D; Robinson MJ; Hall JA; Chappell AS
    Diabetes Care; 2007 Mar; 30(3):664-9. PubMed ID: 17327338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine--three birds with one stone?
    Michel MC
    Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.